These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7931204)

  • 21. Effects of psychiatric care for dual diagnosis patients treated in a drug dependence clinic.
    Saxon AJ; Calsyn DA
    Am J Drug Alcohol Abuse; 1995 Aug; 21(3):303-13. PubMed ID: 7484981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosing comorbidity in substance abusers. Computer assessment and clinical validation.
    Ross HE; Swinson R; Larkin EJ; Doumani S
    J Nerv Ment Dis; 1994 Oct; 182(10):556-63. PubMed ID: 7931203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of antisocial personality subtypes on drug abuse treatment response.
    King VL; Kidorf MS; Stoller KB; Carter JA; Brooner RK
    J Nerv Ment Dis; 2001 Sep; 189(9):593-601. PubMed ID: 11580002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crack/cocaine abusers in the general hospital: assessment and initiation of care.
    Galanter M; Egelko S; De Leon G; Rohrs C; Franco H
    Am J Psychiatry; 1992 Jun; 149(6):810-5. PubMed ID: 1590499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The acute effects of a rapid medical detoxification upon dysphoria and other psychopathology experienced by heroin abusers.
    Ness R; Handelsman L; Aronson MJ; Hershkowitz A; Kanof PD
    J Nerv Ment Dis; 1994 Jun; 182(6):353-9. PubMed ID: 8201308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retention of cocaine abusers in outpatient psychotherapy.
    Kleinman PH; Kang SY; Lipton DS; Woody GE; Kemp J; Millman RB
    Am J Drug Alcohol Abuse; 1992; 18(1):29-43. PubMed ID: 1314014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled study of psychiatric comorbidity in psychiatrically hospitalized young adults with substance use disorders.
    Grilo CM; Martino S; Walker ML; Becker DF; Edell WS; McGlashan TH
    Am J Psychiatry; 1997 Sep; 154(9):1305-7. PubMed ID: 9286195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychiatric and substance-use comorbidities associated with lifetime crack cocaine use in young adults in the general population.
    Narvaez JC; Jansen K; Pinheiro RT; Kapczinski F; Silva RA; Pechansky F; Magalhães PV
    Compr Psychiatry; 2014 Aug; 55(6):1369-76. PubMed ID: 24933652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of early relapse among adolescent crack users.
    Lopes-Rosa R; Kessler FP; Pianca TG; Guimarães L; Ferronato P; Pagnussat E; Moura H; Pechansky F; von Diemen L
    J Addict Dis; 2017; 36(2):136-143. PubMed ID: 28296627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crack Cocaine Use in Adolescents: Clinical Characteristics and Predictors of Early Initiation.
    Pianca TG; Rohde LA; Rosa RL; Begnis AP; Ferronatto PB; Jensen MC; Pechansky F; Ceresér KM; Fairchild VP; Szobot CM
    J Clin Psychiatry; 2016 Oct; 77(10):e1205-e1210. PubMed ID: 27574840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of psychiatric symptomatology on treatment outcome for adolescent male drug abusers.
    Friedman AS; Glickman NW
    J Nerv Ment Dis; 1987 Jul; 175(7):425-30. PubMed ID: 3598570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy.
    Carroll KM; Nich C; Rounsaville BJ
    J Nerv Ment Dis; 1995 Apr; 183(4):251-9. PubMed ID: 7714514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.
    Hasin DS; Trautman KD; Miele GM; Samet S; Smith M; Endicott J
    Am J Psychiatry; 1996 Sep; 153(9):1195-201. PubMed ID: 8780425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychopathology and clinical features in an Italian sample of patients with myofascial and temporomandibular joint pain: preliminary data.
    Nifosì F; Violato E; Pavan C; Sifari L; Novello G; Guarda Nardini L; Manfredini D; Semenzin M; Pavan L; Marini M
    Int J Psychiatry Med; 2007; 37(3):283-300. PubMed ID: 18314857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychiatric comorbidity and severity of dependence on substance users: how it impacts on their health-related quality of life?
    Lozano ÓM; Rojas AJ; Fernández Calderón F
    J Ment Health; 2017 Apr; 26(2):119-126. PubMed ID: 27128492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness.
    Rosenberg SD; Drake RE; Wolford GL; Mueser KT; Oxman TE; Vidaver RM; Carrieri KL; Luckoor R
    Am J Psychiatry; 1998 Feb; 155(2):232-8. PubMed ID: 9464203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of outpatient intensive treatment for drug abuse.
    Campbell J; Gabrielli W; Laster LJ; Liskow BI
    J Addict Dis; 1997; 16(2):15-25. PubMed ID: 9083822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personality disorders in substance abusers: relation to substance use.
    Rounsaville BJ; Kranzler HR; Ball S; Tennen H; Poling J; Triffleman E
    J Nerv Ment Dis; 1998 Feb; 186(2):87-95. PubMed ID: 9484308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated services for treatment of schizophrenic substance abusers: demographics, symptoms, and substance abuse patterns.
    Rosenthal RN; Hellerstein DJ; Miner CR
    Psychiatr Q; 1992; 63(1):3-26. PubMed ID: 1438603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.